At Astellas Oncology, the fight against cancer is personal. Making a positive impact on patients’ lives is the purpose behind everything we do. We strive every day to bring options to hard-to-treat cancers with cutting-edge science and a breakthrough pipeline.
Stay connected for the latest updates
In addition to current treatments for AML, prostate, and urothelial cancers, Astellas Oncology has a robust investigational pipeline. Learn how we’re leading the way when it comes to small molecules, monoclonal antibodies, and novel immuno-oncology approaches under investigation for a variety of hard-to-treat cancers.
Patients are at the heart of everything we do. We focus our efforts where their need is greatest, pushing the boundaries of possibility to deliver treatment and support aimed at improving the lives of patients and caregivers.
It’s an exciting time at Astellas Oncology, where our culture has never been more collaborative. We encourage our employees to think boldly and differently to make every day better for those impacted by cancer.
Astellas Oncology is committed to addressing the complexities of the cancer care journey by fueling the best ideas in cancer care beyond medicine. Our annual C3 Prize was established to spark innovation in cancer care for people with cancer, caregivers, and their loved ones.
Browse through the latest Astellas Oncology news and press releases, stay connected on social media, and contact our internal media team.
You are now leaving www.astellasoncology.com. The website you are linking to is neither owned nor controlled by Astellas. Astellas is not responsible for the content or services on this site.
